Long-Term Remission with Ipilimumab/Nivolumab in Two Patients with Different Soft Tissue Sarcoma Subtypes and No PD-L1 Expression

Checkpoint inhibitor therapy has been shown to improve outcomes in multiple solid malignancies; however, data are limited in soft tissue sarcoma. We present two cases of patients with advanced soft tissue sarcoma of different subtypes (dedifferentiated liposarcoma and myxofibrosarcoma) with zero per...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Maggie, Bui, Nam, Lohman, Marta, van de Rjin, Matt, Hwang, Gloria, Ganjoo, Kristen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991270/
https://www.ncbi.nlm.nih.gov/pubmed/33790767
http://dx.doi.org/10.1159/000512828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991270/
https://www.ncbi.nlm.nih.gov/pubmed/33790767
http://dx.doi.org/10.1159/000512828

Ejemplares similares